Fig. 3
![Fig. 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12885-019-6260-6/MediaObjects/12885_2019_6260_Fig3_HTML.png)
SPAG5 in patients with systematic therapy in univariate analysis. a. Association of SPAG5 with survival outcomes in patients with endocrine therapy. b. Association of SPAG5 with survival outcomes in patients with chemotherapy. c. SPAG5 expression was predictive of relapse in patients with tamoxifen-only therapy. d. SPAG5 expression and survival outcomes in patients with both endocrine therapy and chemotherapy